The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase

被引:216
作者
Rosengren, E
Aman, P
Thelin, S
Hansson, C
Ahlfors, S
Bjork, P
Jacobsson, L
Rorsman, H
机构
[1] UNIV LUND HOSP,CTR BLOOD,S-22185 LUND,SWEDEN
[2] LUND UNIV,DEPT PHARMACOL,S-22362 LUND,SWEDEN
[3] UNIV LUND HOSP,DEPT CLIN GENET,S-22185 LUND,SWEDEN
[4] UNIV LUND HOSP,DEPT DERMATOL,S-22185 LUND,SWEDEN
关键词
macrophage migration inhibitory factor; phenylpyruvate tautomerase; D-dopachrome tautomerase; cytokine;
D O I
10.1016/S0014-5793(97)01261-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A macrophage migration inhibitory factor (MIF), originally described as a product of activated lymphocytes, has been defined as a 12 kDa protein, expressed in a wide variety of tissues. Here MIP is identified as a phenylpyruvate tautomerase (EC 5.3.2.1) having p-hydroxyphenylpyruvate and phenylpyruvate as its natural substrates. The definition of MIF as an enzyme may yield insight into the mechanism of action of this proinflammatory and immunomodulating cytokine. (C) 1997 Federation of European Biochemical Societies.
引用
收藏
页码:85 / 88
页数:4
相关论文
共 37 条
[1]  
AGRUP P, 1989, ACTA DERM-VENEREOL, V69, P120
[2]   SPECIFICITY OF DOPACHROME TAUTOMERASE AND INHIBITION BY CARBOXYLATED INDOLES - CONSIDERATIONS ON THE ENZYME ACTIVE-SITE [J].
AROCA, P ;
SOLANO, F ;
GARCIABORRON, JC ;
LOZANO, JA .
BIOCHEMICAL JOURNAL, 1991, 277 :393-397
[3]   An essential regulatory role for macrophage migration inhibitory factor in T-cell activation [J].
Bacher, M ;
Metz, CN ;
Calandra, T ;
Mayer, K ;
Chesney, J ;
Lohoff, M ;
Gemsa, D ;
Donnelly, T ;
Bucala, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (15) :7849-7854
[4]  
Bacher M, 1997, AM J PATHOL, V150, P235
[5]   MIF IS A PITUITARY-DERIVED CYTOKINE THAT POTENTIATES LETHAL ENDOTOXEMIA [J].
BERNHAGEN, J ;
CALANDRA, T ;
MITCHELL, RA ;
MARTIN, SB ;
TRACEY, KJ ;
VOELTER, W ;
MANOGUE, KR ;
CERAMI, A ;
BUCALA, R .
NATURE, 1993, 365 (6448) :756-759
[6]   PURIFICATION, BIOACTIVITY, AND SECONDARY STRUCTURE-ANALYSIS OF MOUSE AND HUMAN MACROPHAGE-MIGRATION INHIBITORY FACTOR (MIF) [J].
BERNHAGEN, J ;
MITCHELL, RA ;
CALANDRA, T ;
VOELTER, W ;
CERAMI, A ;
BUCALA, R .
BIOCHEMISTRY, 1994, 33 (47) :14144-14155
[7]  
Bjork P, 1996, EUR J HAEMATOL, V57, P254
[8]   MECHANISM OF A REACTION IN VITRO ASSOCIATED WITH DELAYED-TYPE HYPERSENSITIVITY [J].
BLOOM, BR ;
BENNETT, B .
SCIENCE, 1966, 153 (3731) :80-&
[9]   MACROPHAGE IS AN IMPORTANT AND PREVIOUSLY UNRECOGNIZED SOURCE OF MACROPHAGE-MIGRATION INHIBITORY FACTOR [J].
CALANDRA, T ;
BERNHAGEN, J ;
MITCHELL, RA ;
BUCALA, R .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (06) :1895-1902
[10]   MIF AS A GLUCOCORTICOID-INDUCED MODULATOR OF CYTOKINE PRODUCTION [J].
CALANDRA, T ;
BERNHAGEN, J ;
METZ, CN ;
SPIEGEL, LA ;
BACHER, M ;
DONNELLY, T ;
CERAMI, A ;
BUCALA, R .
NATURE, 1995, 377 (6544) :68-71